| Autor: |
Gravelin, Misty, Adamo, Joan E, Ellison, Sharon, Segear, Erika, Parrish, Amanda, Deeter, Christine, Hamill, Jennifer, Soliz, Erik, Idris, Ahamed, Mashour, George A, Weatherwax, Kevin J, Rigan, Laurie |
| Zdroj: |
Journal of Clinical & Translational Science; 2024 Suppl 1, Vol. 8, p152-152, 1p |
| Abstrakt: |
This document is an abstract from the Journal of Clinical & Translational Science. The abstract discusses various topics related to expanded access to investigational drugs and clinical trials. It includes information on the symptoms and outcome measures important to patients with Huntington's disease, the use of the Unified Huntington's Disease Rating Scale (UHDRS) as a common assessment tool, and the demographics and medical conditions of patients receiving expanded access treatments. Additionally, the abstract mentions a pilot program at Mayo Clinic called the Rapid Activation Trial (RAT) program, which aims to expedite the activation of high priority clinical trials. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
